# Semnur Pharmaceuticals, Inc.: Form 8-K, filed Jul 7, 2026

- Company: [Semnur Pharmaceuticals, Inc.](/companies/smnr.md) (CIK 1913577)
- Form: 8-K
- Filed: 2026-07-07
- Accepted by EDGAR: Jul 7, 2026, 10:38 ET
- Period: 2026-07-03
- Accession: 0001193125-26-297085
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/smnr-20260703.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/smnr-20260703.htm

Filed Jul 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-297085. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.